These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 18161120

  • 1. [FACT study].
    Tanaka I, Oshima H.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():280-5. PubMed ID: 18161120
    [No Abstract] [Full Text] [Related]

  • 2. [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate].
    Kishimoto H.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():365-8. PubMed ID: 18161133
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [HIP study--how to prevent hip fractures?].
    Itabashi A.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():286-92. PubMed ID: 18159711
    [No Abstract] [Full Text] [Related]

  • 5. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
    MMW Fortschr Med; 2006 Jun 22; 148(25):60-1. PubMed ID: 16859169
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J, Takeda T, Sato Y.
    Curr Med Res Opin; 2006 May 22; 22(5):919-28. PubMed ID: 16709313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
    Gallagher JC, Rosen CJ, Chen P, Misurski DA, Marcus R.
    Bone; 2006 Dec 22; 39(6):1268-75. PubMed ID: 16884968
    [Abstract] [Full Text] [Related]

  • 10. [New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
    Endo I, Matsumoto T.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():443-6. PubMed ID: 18161146
    [No Abstract] [Full Text] [Related]

  • 11. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R, Lamy O, Peytremann-Bridevaux I.
    Rev Med Suisse; 2008 Dec 10; 4(183):2703. PubMed ID: 19157286
    [No Abstract] [Full Text] [Related]

  • 12. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar 12; 151(11):46-7. PubMed ID: 19469206
    [No Abstract] [Full Text] [Related]

  • 13. [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates].
    MMW Fortschr Med; 2005 Apr 07; 147(14):44. PubMed ID: 15887685
    [No Abstract] [Full Text] [Related]

  • 14. What's the story with Fosamax? Recent reports have women wondering if they should stop taking this widely prescribed osteoporosis drug.
    Harv Womens Health Watch; 2008 Nov 07; 16(3):1-2. PubMed ID: 19043857
    [No Abstract] [Full Text] [Related]

  • 15. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.
    Boonen S, Orwoll ES, Wenderoth D, Stoner KJ, Eusebio R, Delmas PD.
    J Bone Miner Res; 2009 Apr 07; 24(4):719-25. PubMed ID: 19049326
    [Abstract] [Full Text] [Related]

  • 16. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis.
    Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, Barton I, Boonen S.
    Calcif Tissue Int; 2004 Feb 07; 74(2):129-35. PubMed ID: 14648009
    [Abstract] [Full Text] [Related]

  • 17. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD.
    Can Fam Physician; 1998 Feb 07; 44():327-32. PubMed ID: 9512836
    [Abstract] [Full Text] [Related]

  • 18. [Evidence and utility of etidronate for the treatment of osteoporosis].
    Takada J, Iba K, Yamashita T, Yoshizaki T.
    Clin Calcium; 2008 Oct 07; 18(10):1427-33. PubMed ID: 18830039
    [Abstract] [Full Text] [Related]

  • 19. Yearly zoledronic acid in postmenopausal osteoporosis.
    Karam R, Camm J, McClung M.
    N Engl J Med; 2007 Aug 16; 357(7):712-3; author reply 714-5. PubMed ID: 17703529
    [No Abstract] [Full Text] [Related]

  • 20. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar 27; 145(13):60. PubMed ID: 15101545
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.